Edition:
United States

MGC Diagnostics Corp (MGCD.OQ)

MGCD.OQ on NASDAQ Stock Exchange Capital Market

8.06USD
20 Sep 2017
Change (% chg)

-- (--)
Prev Close
$8.06
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,197
52-wk High
$10.45
52-wk Low
$6.24

Chart for

About

MGC Diagnostics Corporation is a medical technology company, which offers cardiorespiratory health solutions. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. It sells its products internationally through distributors and in the United States through a direct sales force targeting... (more)
No analyst recommendations are available for .

Overall

Beta: -0.07
Market Cap(Mil.): $35.71
Shares Outstanding(Mil.): 4.41
Dividend: 0.70
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 178.51 16.33
EPS (TTM): -- -- --
ROI: -- 9.49 14.66
ROE: -- 14.73 13.99

BRIEF-MGC Diagnostics Corp reports Q3 earnings per share $0.17

* MGC diagnostics corporation reports fiscal 2017 third quarter results

Sep 06 2017

BRIEF-MGC Diagnostics appoints Larry R. Degen as interim CFO

* Says on Aug 30, board of co appointed Larry R. Degen as the company’s interim Chief Financial Officer‍​

Sep 01 2017

BRIEF-MGC Diagnostics Q2 loss per share $0.01

* MGC Diagnostics Corporation reports fiscal 2017 second quarter results

Jun 01 2017

BRIEF-MGC Diagnostics announces clinical study to evaluate the diagnostic accuracy of the forced oscillatory technique

* MGC Diagnostics announces clinical study to evaluate the diagnostic accuracy of the Forced Oscillatory Technique (FOT) to detect lung function abnormalities

Apr 20 2017

Competitors

  Price Chg
Becton Dickinson and Co (BDX.N) $192.38 -1.62

Earnings vs. Estimates